Interview: Breast cancer clinical trials: current issues and possible solutions | Zendy

George Dranitsaris | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Interview: Breast cancer clinical trials: current issues and possible solutions

Author(s) -

George Dranitsaris

Publication year - 2013

Publication title -

breast cancer management

Language(s) - English

Resource type - Journals

eISSN - 1758-1931

pISSN - 1758-1923

DOI - 10.2217/bmt.13.27

Subject(s) - medicine , pharmacoeconomics , pharmacy , breast cancer , biostatistics , clinical oncology , alternative medicine , publishing , family medicine , clinical trial , oncology , medical physics , medical education , epidemiology , cancer , intensive care medicine , pathology , political science , law

George Dranitsaris speaks to Alisa Crisp, Commissioning Editor: George Dranitsaris is a health services research consultant with graduate training in biostatistics, pharmacoeconomics, decision analysis and clinical epidemiology. His areas of interest include comparative effectiveness analysis, the measurement of cost-effective drug use in the oncology setting, value-based drug pricing and the evaluation of drug performance outside the trial setting. He has over 100 publications in the national and international literature, is past President of the Canadian Association of Pharmacy in Oncology, a statistical reviewer for the Journal of Clinical Oncology and a member of the editorial board of the Journal of Oncology Pharmacy Practice and the European Journal of Hospital Pharmacy Science.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research